Russell Investments Group, Ltd. Iovance Biotherapeutics, Inc. Transaction History

Russell Investments Group, Ltd.

$60.3 Billion
Q2 2024

A detailed history of Russell Investments Group, Ltd. transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 22,000 shares of IOVA stock, worth $242,660. This represents 0.0% of its overall portfolio holdings.

Number of Shares

22,000

Previous 835 2534.73%

Holding current value

$242,660

Previous $12,000 1366.67%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$7.78 - $14.19 $164,663 - $300,331	21,165 Added 2534.73%	22,000 $176,000
Q1 2024 May 08, 2024	SELL	$7.59 - $17.47 $54,648 - $125,783	-7,200 Reduced 89.61%	835 $12,000
Q4 2023 Feb 05, 2024	SELL	$3.3 - $8.89 $17,440 - $46,983	-5,285 Reduced 39.68%	8,035 $65,000
Q3 2023 Nov 13, 2023	SELL	$4.44 - $8.79 $52,298 - $103,537	-11,779 Reduced 46.93%	13,320 $60,000
Q2 2023 Aug 10, 2023	SELL	$5.36 - $9.06 $758,434 - $1.28 Million	-141,499 Reduced 84.93%	25,099 $176,000
Q1 2023 May 09, 2023	BUY	$5.53 - $8.22 $671,563 - $998,236	121,440 Added 268.92%	166,598 $1.02 Million
Q4 2022 Feb 08, 2023	BUY	$5.62 - $10.0 $144,720 - $257,510	25,751 Added 132.69%	45,158 $288,000
Q3 2022 Nov 04, 2022	SELL	$9.53 - $13.11 $61,535 - $84,651	-6,457 Reduced 24.97%	19,407 $184,000
Q2 2022 Jul 29, 2022	BUY	$6.38 - $18.33 $159,685 - $458,781	25,029 Added 2997.49%	25,864 $284,000
Q1 2022 May 05, 2022	BUY	$12.38 - $19.1 $10,337 - $15,948	835 New	835 $13,000
Q3 2021 Nov 08, 2021	SELL	$20.35 - $26.63 $225,335 - $294,873	-11,073 Closed	0 $0
Q2 2021 Aug 04, 2021	SELL	$16.33 - $33.07 $168,052 - $340,323	-10,291 Reduced 48.17%	11,073 $287,000
Q1 2021 May 10, 2021	BUY	$28.67 - $52.59 $298,741 - $547,987	10,420 Added 95.21%	21,364 $675,000
Q3 2020 Nov 09, 2020	SELL	$27.75 - $36.3 $1.4 Million - $1.84 Million	-50,630 Reduced 82.23%	10,944 $360,000
Q2 2020 Aug 05, 2020	SELL	$27.21 - $41.0 $628,959 - $947,715	-23,115 Reduced 27.29%	61,574 $1.69 Million
Q1 2020 May 06, 2020	SELL	$19.54 - $38.85 $3,575 - $7,109	-183 Reduced 0.22%	84,689 $2.53 Million
Q4 2019 Jan 29, 2020	BUY	$17.95 - $29.41 $655,534 - $1.07 Million	36,520 Added 75.53%	84,872 $2.35 Million
Q3 2019 Nov 01, 2019	BUY	$17.99 - $26.0 $869,852 - $1.26 Million	48,352 New	48,352 $880,000
Q4 2017 Feb 06, 2018	SELL	$6.65 - $9.25 $111,267 - $154,771	-16,732 Closed	0 $0
Q3 2017 Nov 07, 2017	BUY	$4.45 - $8.55 $74,457 - $143,058	16,732	16,732 $130,000

Others Institutions Holding IOVA

# of Institutions

320

Shares Held

238M

Call Options Held

1.27M

Put Options Held

1.68M

View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.74B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

More about IOVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Account

Russell Investments Group, Ltd. Iovance Biotherapeutics, Inc. Transaction History